Abstract:Dermatophyte infections, also known as tinea or ringworm, remain an important public health concern worldwide. Dermatophytes consist of more than 30 species of common and rare contagious filamentous fungi that can invade keratinized tissues and cause superficial infections of the skin, nail, and hair [1]. Infections are acquired from contact with infected humans, animals, soil, or contaminated fomites. Secondary spread from other infected body sites can occur. Infections caused by dermatophytes are considered the most common fungal diseases in humans [2]. It is estimated that more than 20% to 25% of the world population is affected by these superficial fungal skin diseases [3]. The clinical spectrum of dermatophytosis, range from onychomycosis (i.e., nail infection) and tinea pedis (i.e., athlete's foot) to the inflammatory lesions of tinea corporis and tinea capitis (i.e., skin and scalp ringworm, respectively) [4]. Anthropophilic dermatophyte species usually cause desquamative and pruritic lesions with a low level of inflammation, the most common being Trichophyton rubrum , T . interdigitale , T . tonsurans , T . violaceum , T . soudanense , and Microsporum audouinii . In contrast, zoophilic, mostly T . mentagrophytes and M . canis , and geophilic species are responsible for more inflammatory lesions when infecting the human host [5]. Dermatophytosis have been commonly managed with terbinafine, this being the first line treatment since the 1990s [6]. The past decade has witnessed the emergence of an increased number of dermatophyte infections with unusual clinical manifestations and/or mode of transmission including deep (i.e., invasive) [7], extensive (i.e., unusual extent of skin surface or multiple affected sites) [8], difficult-to-treat (i.e., not responding to standard course of first line treatment) [9] or sexually transmitted dermatophytosis [10]. Herein, we use "complex dermatophytosis" to refer to these infections collectively. The challenges associated with unusual clinical presentations of dermatophytosis include delayed- or mis-diagnosis, leading to unnecessary prescription of antibiotics and/or topical steroids often masking or worsening the preliminary symptoms. Subsequent delayed or ineffective interventions lead to continuous transmission of the disease. Furthermore, unusual outbreaks of various zoophilic dermatophytes and their transmission to human populations in recent years is of concern [11,12]. In this rapidly evolving context, we provide an overview of the current clinical challenges in the ever-expanding spectrum of dermatomycology and the dermatophyte pathogens involved. We highlight potential key priorities for future research in the integration and management of complex dermatophyte infections.

Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United States

Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance

State-of-the-Art Dermatophyte Infections: Epidemiology Aspects, Pathophysiology, and Resistance Mechanisms

Antifungal Patterns of Dermatophytes: A Pathway to Antifungal Stewardship in Eastern India

A Study of In vitro Antifungal Susceptibility Patterns of Dermatophytic Fungi at a Tertiary Care Center in Western India

An international survey of recalcitrant and recurrent tinea of the glabrous skin—A potential indicator of antifungal resistance

Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management

Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis

Clinical study on antifungal drug resistance among cases of dermatophytosis in patients reporting to multiple tertiary care hospitals

Emerging Fungal Infections: from the Fields to the Clinic, Resistant Aspergillus fumigatus and Dermatophyte Species: a One Health Perspective on an Urgent Public Health Problem

Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates

Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settings

Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)

Current and emerging issues in dermatophyte infections

A clinical-mycological study of dermatophytosis in western India with focus on antifungal drug resistance as a factor in recalcitrance

Clinicians' Challenges in Managing Patients with Invasive Fungal Diseases in Seven Asian Countries: an Asia Fungal Working Group (AFWG) Survey.

Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study

Recalcitrant cutaneous fungal infections-A growing problem

Dermatologic Fungal Neglected Tropical Diseases—Part I. Epidemiology and Clinical Features

Antifungal Drug Resistance: An Emergent Health Threat

The need for fast and accurate detection of dermatomycosis